Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment
Ended Awarded
- Contract number
- HT009025FG0210044
- Awardee
-
Sofie CO. UEI JV1AHJHGUGG3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $21,652
Award facts
- Contract value 100% obligated
- $21,652.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as IBA Molecular, to provide radiopharmaceuticals needed for the treatment of prostate cancer patients with metastatic lesions. The contract has a ceiling value of $21,652.32 and is effective through September 30, 2025.
Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a for-profit organization specializing in the development, production, and delivery of molecular diagnostics and therapeutics, with a focus on radiopharmaceuticals and positron emission tomography (PET) imaging agents. The company has been a key supplier of specialized medical imaging products and radiopharmaceuticals to federal healthcare agencies, including the Department of Veterans Affairs (VA) and DHA, under various prime contract awards and Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs).
This contract is not set aside and is part of Sofie's broader portfolio of federal contract awards for specialized radiopharmaceuticals used in medical diagnostic procedures, cancer detection, and treatment tracking.
Quick answers
Who was awarded contract HT009025FG0210044?
HT009025FG0210044 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on February 10, 2025.
How much is contract HT009025FG0210044 worth?
The government has obligated $21,652 on HT009025FG0210044.
Is contract HT009025FG0210044 an order under another contract?
Yes. HT009025FG0210044 is a BPA call under HT001424A0002, a blanket purchase agreement.
Was contract HT009025FG0210044 competed?
The extent of competition for HT009025FG0210044 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award